Skip to content
  • About
  • Contact
  • Contribute
  • Book
  • Careers
  • Podcast
  • Recommended
  • Speaking
  • All
  • Physician
  • Practice
  • Policy
  • Finance
  • Conditions
  • .edu
  • Patient
  • Meds
  • Tech
  • Social
  • Video
    • All
    • Physician
    • Practice
    • Policy
    • Finance
    • Conditions
    • .edu
    • Patient
    • Meds
    • Tech
    • Social
    • Video
    • About
    • Contact
    • Contribute
    • Book
    • Careers
    • Podcast
    • Recommended
    • Speaking

Should drug use be decriminalized?

Katya Korol and Sarah Fraser, MD
Policy
November 7, 2020
Share
Tweet
Share

During the final presidential debate, Joe Biden said that “no one should be going to jail for a drug problem, they should be going to rehabilitation,” effectively suggesting that substance use be decriminalized in the US.

The war on drugs

Since President Nixon declared the “war on drugs” nearly half a century ago, the general global response to drug use has been focused on enforcement. Zero tolerance. Since the Nixon years, drug-related incarceration has been on the rise. But has this approach actually worked to stop people from using drugs? The short answer is no. In fact, substance use problems are worsening. According to the Center for Disease Control and Prevention, drug-related overdose rates increased by 9.6% between the years 2016 and 2017.

It is well known that addiction is a health issue, yet it continues to be treated like a crime. The war on drugs is an ineffective approach, and the U.S. government must quickly move to decriminalize personal drug use. In fact, it is a matter of life and death.

Where did the war on drugs come from?

Many of us grew up repeatedly hearing, “don’t do drugs.” The idea that drugs are bad and that drug policies exist to protect us from chemical danger is perhaps an intuitive one. Science may have played a role in shaping enforcement policies, but moral values and public perceptions that drug use is related to a lower social class also influenced our understandings and policies around drugs. Today we know that enforcement-based policies are not based on science.

Portugal and decriminalization of drugs

In Portugal, the punitive, zero-tolerance approach for addressing addiction was not working. Portuguese policymakers looked for another answer. They consulted with academics and medical professionals about the country’s drug problem, who suggested that the government opt for a less stigmatized approach to addiction treatment. So Portugal passed a law making drug use and possession (up to a ten-day supply) an administrative offense rather than a criminal one. Effectively, the Portuguese government decriminalized all drug use and possession, including heroin and cocaine. To be clear, trafficking and selling drugs are still considered to be crimes. However, using drugs is instead met with fines or community service rather than jail time.

Despite political pressures to join the international War on Drugs, Portugal did not. They were the first country to decriminalize all drugs. It was a highly controversial policy at the time, but after decriminalizing all personal drug use, there was a decline in addiction, HIV, and drug-related mortality rates, as well as a relative decline in drug use itself. In other words, by using a polar opposite technique to address substance use problems, Portugal reduced drug use rates, as well as the associated harms and burdens.

Did people in Portugal start using more drugs? 

Yes and no. In some age groups, drug use went down. This includes the age group of 13 to 18 year olds. This decrease is particularly important because drug use often begins in the teenage years.

On the other hand, small increases in substance use were observed in some adults (including 19 to 24 year olds). Although overall drug use in some age groups increased, this can mostly be accounted for by the increase in hashish use (a drug derived from the cannabis plant), while the use of other substances barely increased. This is important because cannabis is considered much less harmful to self and society than intravenous drugs like heroin or even alcohol.

Does decriminalization reduce drug-related harms?

Harms that go along with drug use have been significantly reduced in Portugal. Particularly, HIV and AIDS cases among IV drug users decreased after decriminalization. Before decriminalization, 50% of HIV cases were related to drug use, whereas seven years after, only 20% of HIV cases were drug use-related. There were fewer overdoses, and crime rates also went down. Portugal, like most countries, has a public prison system. The lower incarceration rates are saving the system money, allowing for the reallocation of these resources.

ADVERTISEMENT

Though Portugal was the first country to tread these unchartered waters, other countries have benefited from this harm reduction approach. Switzerland has changed its laws to possess small amounts of drugs for personal or shared use was no longer a crime. Instead of focusing on the user, they instead focus on targeting large-scale traffickers. They’ve connected with financial experts to detect abnormal money laundering from the drug trade. Drugs have also been decriminalized in Norway, and cases have been moved from the Justice Sector to the Health Sector.

Should the U.S. decriminalize drugs?

The U.S.’ punitive approach to illicit drug use isn’t working. Rates of prescription opioid overdose in the US increased fivefold between the years 1999 and 2016. Further, rates of maternal opioid use and neonatal abstinence syndrome have been dramatically increasing. The NIH estimates that every fifteen minutes, a baby is born suffering from opioid withdrawal.

We also know that the burden of substance use problems is unequally distributed due to ongoing systemic racism. A study by researchers at the Harvard Law School recently found that Black and Latino defendants in Massachusetts are more likely than their White counterparts to be arrested and convicted of drug-related charges.

Addressing addiction is a complex endeavor that should best support people suffering from substance use problems and society as a whole. Portugal’s decriminalization policies seem to do this pretty well.

Katya Korol is a graduate student. Sarah Fraser is a family physician who can be reached at her self-titled site, Sarah Fraser MD. She is the author of Humanities Emergency.

Image credit: Shutterstock.com 

Prev

Moving forward in medicine with your significant other

November 7, 2020 Kevin 0
…
Next

Female physician suicides: a silent pandemic

November 7, 2020 Kevin 0
…

Tagged as: Public Health & Policy

Post navigation

< Previous Post
Moving forward in medicine with your significant other
Next Post >
Female physician suicides: a silent pandemic

ADVERTISEMENT

Related Posts

  • How hospitals can impact generic drug companies

    Mark Kelley, MD
  • A drug problem in rural Georgia

    Ashish Advani, PharmD
  • Drug ads are a campaign against physician trust

    Judy Salz, MD
  • Crippling drug costs: the role of insurers

    Janice Boughton, MD
  • The complications of drug regulation

    Julie Craig, MD
  • The promise of in silico drug development to improve patient outcomes

    Tanja Dowe

More in Policy

  • Why medical organizations must end their silence

    Marilyn Uzdavines, JD & Vijay Rajput, MD
  • The flaw in the ACA’s physician ownership ban

    Luis Tumialán, MD
  • The paradox of primary care and value-based reform

    Troyen A. Brennan, MD, MPH
  • a desk with keyboard and ipad with the kevinmd logo

    Deaths in custody highlight crisis in Philly prisons

    Kendall Major, MD, Tommy Gautier, MD, Alyssa Lambrecht, DO, and Elle Saine, MD
  • South Carolina’s CON repeal: an opportunity for doctors

    Marcelo Hochman, MD
  • Why ACA subsidies aren’t the main issue

    Andrew Murphy, MD
  • Most Popular

  • Past Week

    • Rebuilding the backbone of health care [PODCAST]

      The Podcast by KevinMD | Podcast
    • Why you should get your Lp(a) tested

      Monzur Morshed, MD and Kaysan Morshed | Conditions
    • The paradox of primary care and value-based reform

      Troyen A. Brennan, MD, MPH | Policy
    • Why CPT coding ambiguity harms doctors

      Muhamad Aly Rifai, MD | Physician
    • The flaw in the ACA’s physician ownership ban

      Luis Tumialán, MD | Policy
    • Reimagining medical education for the 21st century [PODCAST]

      The Podcast by KevinMD | Podcast
  • Past 6 Months

    • Rebuilding the backbone of health care [PODCAST]

      The Podcast by KevinMD | Podcast
    • The dangerous racial bias in dermatology AI

      Alex Siauw | Tech
    • When language barriers become a medical emergency

      Monzur Morshed, MD and Kaysan Morshed | Physician
    • The dismantling of public health infrastructure

      Ronald L. Lindsay, MD | Physician
    • The high cost of PCSK9 inhibitors like Repatha

      Larry Kaskel, MD | Conditions
    • A neurosurgeon’s fight with the state medical board [PODCAST]

      The Podcast by KevinMD | Podcast
  • Recent Posts

    • Advance directives not honored: a wife’s story

      Susan Hatch | Conditions
    • Why billionaires dress like college students

      Osmund Agbo, MD | Physician
    • The therapy memory recall crisis

      Ronke Lawal | Conditions
    • A urologist explains premature ejaculation

      Martina Ambardjieva, MD, PhD | Conditions
    • Why medical organizations must end their silence

      Marilyn Uzdavines, JD & Vijay Rajput, MD | Policy
    • The flaw in the ACA’s physician ownership ban

      Luis Tumialán, MD | Policy

Subscribe to KevinMD and never miss a story!

Get free updates delivered free to your inbox.


Find jobs at
Careers by KevinMD.com

Search thousands of physician, PA, NP, and CRNA jobs now.

Learn more

Leave a Comment

Founded in 2004 by Kevin Pho, MD, KevinMD.com is the web’s leading platform where physicians, advanced practitioners, nurses, medical students, and patients share their insight and tell their stories.

Social

  • Like on Facebook
  • Follow on Twitter
  • Connect on Linkedin
  • Subscribe on Youtube
  • Instagram

ADVERTISEMENT

ADVERTISEMENT

  • Most Popular

  • Past Week

    • Rebuilding the backbone of health care [PODCAST]

      The Podcast by KevinMD | Podcast
    • Why you should get your Lp(a) tested

      Monzur Morshed, MD and Kaysan Morshed | Conditions
    • The paradox of primary care and value-based reform

      Troyen A. Brennan, MD, MPH | Policy
    • Why CPT coding ambiguity harms doctors

      Muhamad Aly Rifai, MD | Physician
    • The flaw in the ACA’s physician ownership ban

      Luis Tumialán, MD | Policy
    • Reimagining medical education for the 21st century [PODCAST]

      The Podcast by KevinMD | Podcast
  • Past 6 Months

    • Rebuilding the backbone of health care [PODCAST]

      The Podcast by KevinMD | Podcast
    • The dangerous racial bias in dermatology AI

      Alex Siauw | Tech
    • When language barriers become a medical emergency

      Monzur Morshed, MD and Kaysan Morshed | Physician
    • The dismantling of public health infrastructure

      Ronald L. Lindsay, MD | Physician
    • The high cost of PCSK9 inhibitors like Repatha

      Larry Kaskel, MD | Conditions
    • A neurosurgeon’s fight with the state medical board [PODCAST]

      The Podcast by KevinMD | Podcast
  • Recent Posts

    • Advance directives not honored: a wife’s story

      Susan Hatch | Conditions
    • Why billionaires dress like college students

      Osmund Agbo, MD | Physician
    • The therapy memory recall crisis

      Ronke Lawal | Conditions
    • A urologist explains premature ejaculation

      Martina Ambardjieva, MD, PhD | Conditions
    • Why medical organizations must end their silence

      Marilyn Uzdavines, JD & Vijay Rajput, MD | Policy
    • The flaw in the ACA’s physician ownership ban

      Luis Tumialán, MD | Policy

MedPage Today Professional

An Everyday Health Property Medpage Today
  • Terms of Use | Disclaimer
  • Privacy Policy
  • DMCA Policy
All Content © KevinMD, LLC
Site by Outthink Group

Leave a Comment

Comments are moderated before they are published. Please read the comment policy.

Loading Comments...